Cardiovascular Health Improvement Project
Launched by UNIVERSITY OF MICHIGAN · Dec 1, 2014
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Cardiovascular Health Improvement Project is a research study aimed at better understanding heart and blood vessel conditions, such as aortic aneurysms, aortic dissections, and heart failure. The main goal is to collect important samples, including blood and tissue, from both patients with these cardiovascular diseases and healthy individuals. This information will help researchers learn more about these conditions and potentially improve treatments in the future.
If you are over 18 years old and can give your consent, or if you are under 18 with permission from a parent or guardian, you may be eligible to participate. The study is looking for individuals diagnosed with certain heart conditions, as well as healthy people without any known cardiovascular issues. Participants can expect to provide samples and health information, contributing to valuable research that could benefit many others with similar health concerns. This study is currently recruiting participants of all genders, so if you're interested, you could help make a difference in cardiovascular health research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient over the age of 18 who is able/willing to give informed consent
- • Patients \<18 years of age with parental consent and assent (if assent is applicable for their age)
- * Diagnosis of:
- • aortic pathology potentially due to a known or suspected inherited condition
- • Idiopathic aortic aneurysm
- • Interesting of novel vascular pathology in the aorta or main branches
- • Family history of aortic or vascular disease
- • Other cardiovascular disease
- • Healthy controls with no apparent cardiovascular disease
- Exclusion Criteria:
- • - Not willing or able to sign the consent
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Marion A Hofmann Bowman, PhD, MD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials